Caroline Helwick[email protected]MRIBreast MRI pinpoints residual disease after chemotherapyBreast MRI accurately reflects the pathologic extent of residual disease following neoadjuvant chemotherapy, and tumor size and contrast kinetics measured by MRI may be useful early predictors of treatment response, according to a study presented at the San Antonio Breast Cancer Symposium.December 18, 2008Page 1 of 1Top StoriesPractice ManagementThe mangling of medical EnglishIn a new column, U.K. radiologist Paul McCoubrie, MBBS, reflects on the variety of ways radiologists can mangle medical English.Image ProcessingFDA issues final order reclassifying radiological CAD softwareAIAI improves MRI diagnosis of prostate cancerMolecular ImagingPSMA-PET/CT improves survival in men with prostate cancerSponsor ContentRegister today for our June 17 webinar
